GRAIL
GRALHealthcare · Diagnostics & Research · US99.25USDGRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally.
1D−5.3%1W−14.4%1M−25.1%
Loading chart…
Checks
- Locked: Price trend
- Locked: Sales growth against its peers
- Locked: Profit against similar companies
- Locked: What analysts expect
- Locked: Price against what it earns
- Locked: Last quarter against forecasts
See how GRAIL does on each check. Sign in for two weeks free, with no card. Then StratDeck Pro is £5.99 a month or £60 a year.
Sign in